{"transactions":[{"id":834108,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":57254,"kind":"person","name":"Wang Xiaolin","position":1,"cik":"0001849181","reported_name":"Wang Xiaolin","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-03-19T18:53:55.000Z","date":"2026-03-17","kind":"sale","planned":true,"acquired":false,"shares":2010,"price":99.4804,"value":199955.604,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a Rule 10b5-1 instruction letter adopted on November 17, 2025 to satisfy the Reporting Person's tax withholding obligation upon the vesting of restricted stock units (\"RSUs\") after December 15, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 48,700 RSUs."}],"balance_after":116063,"source":{"system":"sec-edgar","filing":"0001610717-26-000126","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1849181/000161071726000126/form4.xml","form_type":"4"}},{"id":871532,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":57254,"kind":"person","name":"Wang Xiaolin","position":1,"cik":"0001849181","reported_name":"Wang Xiaolin","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-03T21:11:14.000Z","date":"2026-03-01","kind":"grant","planned":false,"acquired":true,"shares":34000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One forty-eighth (1/48th) of the shares initially subject to the option will vest on each monthly anniversary measured from March 1, 2026 (the \"Vesting Commencement Date\"), so that 100% of the shares subject to the option will be fully vested and exercisable as of the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service through each vesting date."}],"balance_after":34000,"derivative":{"exercise_price":102.02,"expiration_date":"2036-02-28","underlying":"Common Stock","underlying_shares":34000},"source":{"system":"sec-edgar","filing":"0001610717-26-000085","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1849181/000161071726000085/form4.xml","form_type":"4"}},{"id":871531,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":57254,"kind":"person","name":"Wang Xiaolin","position":1,"cik":"0001849181","reported_name":"Wang Xiaolin","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-03-03T21:11:14.000Z","date":"2026-03-01","kind":"grant","planned":false,"acquired":true,"shares":15100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 54,464 restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 652 shares acquired under the Issuer's Employee Stock Purchase Plan on May 31, 2025."}],"balance_after":118073,"source":{"system":"sec-edgar","filing":"0001610717-26-000085","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1849181/000161071726000085/form4.xml","form_type":"4"}},{"id":1197700,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":57254,"kind":"person","name":"Wang Xiaolin","position":1,"cik":"0001849181","reported_name":"Wang Xiaolin","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-03-19T17:40:18.000Z","date":"2025-03-17","kind":"gift","planned":false,"acquired":false,"shares":2718,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 56,650 restricted stock units."}],"balance_after":102321,"source":{"system":"sec-edgar","filing":"0001610717-25-000076","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1849181/000161071725000076/form4.xml","form_type":"4"}},{"id":1232649,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":57254,"kind":"person","name":"Wang Xiaolin","position":1,"cik":"0001849181","reported_name":"Wang Xiaolin","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-03-04T19:01:07.000Z","date":"2025-03-01","kind":"grant","planned":false,"acquired":true,"shares":66500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One forty-eighth (1/48th) of the shares initially subject to the option will vest on each monthly anniversary measured from March 1, 2025 (the \"Vesting Commencement Date\"), so that 100% of the shares subject to the option will be fully vested and exercisable as of the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service through each vesting date."}],"balance_after":66500,"derivative":{"exercise_price":40.74,"expiration_date":"2035-02-28","underlying":"Common Stock","underlying_shares":66500},"source":{"system":"sec-edgar","filing":"0001610717-25-000051","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1849181/000161071725000051/form4.xml","form_type":"4"}},{"id":1232648,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":57254,"kind":"person","name":"Wang Xiaolin","position":1,"cik":"0001849181","reported_name":"Wang Xiaolin","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-03-04T19:01:07.000Z","date":"2025-03-01","kind":"grant","planned":false,"acquired":true,"shares":19000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 61,926 restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,513 shares acquired under the Issuer's Employee Stock Purchase Plan on May 31, 2024."}],"balance_after":105039,"source":{"system":"sec-edgar","filing":"0001610717-25-000051","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1849181/000161071725000051/form4.xml","form_type":"4"}},{"id":1599978,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":57254,"kind":"person","name":"Wang Xiaolin","position":1,"cik":"0001849181","reported_name":"Wang Xiaolin","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-03-05T16:52:43.000Z","date":"2024-03-01","kind":"grant","planned":false,"acquired":true,"shares":84700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One forty-eighth (1/48th) of the shares initially subject to the option will vest on each monthly anniversary measured from March 1, 2024 (the \"Vesting Commencement Date\"), so that 100% of the shares subject to the option will be fully vested and exercisable as of the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service through each vesting date."}],"balance_after":84700,"derivative":{"exercise_price":29.8,"expiration_date":"2034-02-28","underlying":"Common Stock","underlying_shares":84700},"source":{"system":"sec-edgar","filing":"0001610717-24-000129","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1849181/000161071724000129/form4.xml","form_type":"4"}},{"id":1599977,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":57254,"kind":"person","name":"Wang Xiaolin","position":1,"cik":"0001849181","reported_name":"Wang Xiaolin","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-03-05T16:52:43.000Z","date":"2024-03-01","kind":"grant","planned":false,"acquired":true,"shares":24200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 62,513 restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,513 shares acquired under the Issuer's Employee Stock Purchase Plan on May 31, 2023."}],"balance_after":84526,"source":{"system":"sec-edgar","filing":"0001610717-24-000129","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1849181/000161071724000129/form4.xml","form_type":"4"}},{"id":1943731,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":57254,"kind":"person","name":"Wang Xiaolin","position":1,"cik":"0001849181","reported_name":"Wang Xiaolin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2023-03-21T20:32:03.000Z","date":"2023-03-17","kind":"sale","planned":false,"acquired":false,"shares":714,"price":21.78,"value":15550.92,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to an automatic sell-to-cover imposed by the terms of the restricted stock units (\"RSUs\") award, the shares were sold following the vesting of the RSUs solely to cover applicable withholding taxes."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades in prices ranging from $21.4075 to $21.784581, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 49,600 RSUs."}],"balance_after":58813,"source":{"system":"sec-edgar","filing":"0000899243-23-009372","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1849181/000089924323009372/doc4.xml","form_type":"4"}},{"id":1976650,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":57254,"kind":"person","name":"Wang Xiaolin","position":1,"cik":"0001849181","reported_name":"Wang Xiaolin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-03-03T16:17:11.000Z","date":"2023-03-01","kind":"grant","acquired":true,"shares":101500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One forty-eighth (1/48th) of the shares initially subject to the option will vest on each monthly anniversary measured from March 1, 2023 (the \"Vesting Commencement Date\"), so that 100% of the shares subject to the option will be fully vested and exercisable as of the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service through each vesting date."}],"balance_after":101500,"derivative":{"exercise_price":26.5,"expiration_date":"2033-02-28","underlying":"Common Stock","underlying_shares":101500},"source":{"system":"sec-edgar","filing":"0001567619-23-004354","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1849181/000156761923004354/doc1.xml","form_type":"4"}},{"id":1976649,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":57254,"kind":"person","name":"Wang Xiaolin","position":1,"cik":"0001849181","reported_name":"Wang Xiaolin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2023-03-03T16:17:11.000Z","date":"2023-03-01","kind":"grant","acquired":true,"shares":29000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 51,550 restricted stock units."}],"balance_after":59527,"source":{"system":"sec-edgar","filing":"0001567619-23-004354","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1849181/000156761923004354/doc1.xml","form_type":"4"}},{"id":2079161,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":57254,"kind":"person","name":"Wang Xiaolin","position":1,"cik":"0001849181","reported_name":"Wang Xiaolin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2022-12-21T16:07:22.000Z","date":"2022-12-19","kind":"sale","acquired":false,"shares":708,"price":22.9398,"value":16241.3784,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to an automatic sell-to-cover imposed by the terms of the restricted stock units (\"RSUs\") award, the shares were sold following the vesting of the RSUs solely to cover applicable withholding taxes."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades in prices ranging from $22.4706 to $22.96, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 22,550 RSUs."}],"balance_after":30527,"source":{"system":"sec-edgar","filing":"0001567619-22-021928","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1849181/000156761922021928/doc1.xml","form_type":"4"}},{"id":2153701,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":57254,"kind":"person","name":"Wang Xiaolin","position":1,"cik":"0001849181","reported_name":"Wang Xiaolin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2022-09-21T16:18:51.000Z","date":"2022-09-19","kind":"sale","acquired":false,"shares":735,"price":19.0426,"value":13996.311,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to an automatic sell-to-cover imposed by the terms of the restricted stock units (\"RSUs\") award, the shares were sold following the vesting of the RSUs solely to cover applicable withholding taxes."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades in prices ranging from $18.98 to $19.0337, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 24,500 RSUs."}],"balance_after":31235,"source":{"system":"sec-edgar","filing":"0001567619-22-017692","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1849181/000156761922017692/doc1.xml","form_type":"4"}},{"id":2224726,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":57254,"kind":"person","name":"Wang Xiaolin","position":1,"cik":"0001849181","reported_name":"Wang Xiaolin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2022-06-22T17:03:42.000Z","date":"2022-06-17","kind":"sale","acquired":false,"shares":665,"price":17.7495,"value":11803.4175,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to an automatic sell-to-cover imposed by the terms of the restricted stock units (\"RSUs\") award, the shares were sold following the vesting of the RSUs solely to cover applicable withholding taxes."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 937 shares acquired under the Issuer's Employee Stock Purchase Plan on May 31, 2022."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 26,450 RSUs."}],"balance_after":31970,"source":{"system":"sec-edgar","filing":"0001567619-22-013253","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1849181/000156761922013253/doc1.xml","form_type":"4"}},{"id":2323699,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":57254,"kind":"person","name":"Wang Xiaolin","position":1,"cik":"0001849181","reported_name":"Wang Xiaolin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2022-03-21T20:02:35.000Z","date":"2022-03-17","kind":"sale","acquired":false,"shares":240,"price":18.6142,"value":4467.408,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units (\"RSUs\") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades in prices ranging from $18.1558 to $18.62, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 28,400 RSUs."}],"balance_after":31698,"source":{"system":"sec-edgar","filing":"0001567619-22-007325","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1849181/000156761922007325/doc1.xml","form_type":"4"}},{"id":2357403,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":57254,"kind":"person","name":"Wang Xiaolin","position":1,"cik":"0001849181","reported_name":"Wang Xiaolin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-03-03T16:25:40.000Z","date":"2022-03-01","kind":"grant","acquired":true,"shares":70000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One forty-eighth (1/48th) of the shares initially subject to the option will vest on each monthly anniversary measured from March 1, 2022 (the \"Vesting Commencement Date\"), so that 100% of the shares subject to the option will be fully vested and exercisable as of the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service through each vesting date."}],"balance_after":70000,"derivative":{"exercise_price":18.56,"expiration_date":"2032-02-29","underlying":"Common Stock","underlying_shares":70000},"source":{"system":"sec-edgar","filing":"0001567619-22-006233","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1849181/000156761922006233/doc1.xml","form_type":"4"}},{"id":2357402,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":57254,"kind":"person","name":"Wang Xiaolin","position":1,"cik":"0001849181","reported_name":"Wang Xiaolin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2022-03-03T16:25:40.000Z","date":"2022-03-01","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 29,100 Restricted Stock Units."}],"balance_after":31938,"source":{"system":"sec-edgar","filing":"0001567619-22-006233","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1849181/000156761922006233/doc1.xml","form_type":"4"}},{"id":2463210,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":57254,"kind":"person","name":"Wang Xiaolin","position":1,"cik":"0001849181","reported_name":"Wang Xiaolin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2021-12-21T16:33:37.000Z","date":"2021-12-17","kind":"sale","acquired":false,"shares":257,"price":24.41,"value":6273.37,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units (\"RSUs\") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 9,100 RSUs."}],"balance_after":11938,"source":{"system":"sec-edgar","filing":"0001567619-21-022404","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1849181/000156761921022404/doc1.xml","form_type":"4"}},{"id":2563521,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":57254,"kind":"person","name":"Wang Xiaolin","position":1,"cik":"0001849181","reported_name":"Wang Xiaolin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2021-09-21T19:47:40.000Z","date":"2021-09-17","kind":"sale","acquired":false,"shares":250,"price":30.02,"value":7505.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units (\"RSUs\") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 9,800 RSUs."}],"balance_after":12195,"source":{"system":"sec-edgar","filing":"0001567619-21-017415","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1849181/000156761921017415/doc1.xml","form_type":"4"}},{"id":2659621,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":57254,"kind":"person","name":"Wang Xiaolin","position":1,"cik":"0001849181","reported_name":"Wang Xiaolin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2021-06-22T17:19:41.000Z","date":"2021-06-17","kind":"sale","acquired":false,"shares":243,"price":34.1209,"value":8291.3787,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units (\"RSUs\") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades in prices ranging from $33.37 to $34.22, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 744 shares acquired under the Issuer's Employee Stock Purchase Plan on May 31, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes 10,500 RSUs."}],"balance_after":12445,"source":{"system":"sec-edgar","filing":"0001567619-21-012491","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1849181/000156761921012491/doc1.xml","form_type":"4"}},{"id":2804270,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":57254,"kind":"person","name":"Wang Xiaolin","position":1,"cik":"0001849181","reported_name":"Wang Xiaolin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-03-08T19:41:16.000Z","date":"2021-03-04","kind":"grant","acquired":true,"shares":39200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One forty-eighth (1/48th) of the shares initially subject to the option will vest on each monthly anniversary measured from March 4, 2021 (the \"Vesting Commencement Date\"), so that 100% of the shares subject to the option will be fully vested and exercisable as of the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service through each vesting date."}],"balance_after":39200,"derivative":{"exercise_price":42.45,"expiration_date":"2031-03-03","underlying":"Common Stock","underlying_shares":39200},"source":{"system":"sec-edgar","filing":"0001567619-21-005846","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1849181/000156761921005846/doc1.xml","form_type":"4"}},{"id":2804269,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":57254,"kind":"person","name":"Wang Xiaolin","position":1,"cik":"0001849181","reported_name":"Wang Xiaolin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2021-03-08T19:41:16.000Z","date":"2021-03-04","kind":"grant","acquired":true,"shares":11200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 11,200 Restricted Stock Units."}],"balance_after":11944,"source":{"system":"sec-edgar","filing":"0001567619-21-005846","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1849181/000156761921005846/doc1.xml","form_type":"4"}}]}